Mehrad Jaloli

Mr. Mehrad Jaloli

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
MJMehrad Jaloli
Mehrad Jaloli
MCMarzia Cescon
Marzia Cescon
Background: In this work, we leverage state-of-the-art deep learning–based algorithms for blood glucose (BG) forecasting in people with type 1 diabetes. Methods: We propose stacks of convolutional neural network and long short-term memory units to predict BG level for 30-, 60-, and 90-minute prediction horizon (PH), given historical glucose measurements, meal information, and insulin intakes. The evaluation was performed on two data sets, Replace-BG and DIAdvisor, representative of free-living conditions and in-hospital setting, respectively. Results: For 90-minute PH, our model obtained mean absolute error of 17.30 ± 2.07 and 18.23 ± 2.97 mg/dL, root mean square error of 23.45 ± 3.18 and 25.12 ± 4.65 mg/dL, coefficient of determination of 84.13 ± 4.22% and 82.34 ± 4.54%, and in terms of the continuous glucose-error grid analysis 94.71 ± 3.89% and 91.71 ± 4.32% accurate predictions, 1.81 ± 1.06% and 2.51 ± 0.86% benign errors, and 3.47 ± 1.12% and 5.78 ± 1.72% erroneous predictions, for Replace-BG and DIAdvisor data sets, respectively. Conclusion: Our investigation demonstrated that our method achieved superior glucose forecasting compared with existing approaches in the literature, and thanks to its generalizability showed potential for real-life applications.

31 December 2023 in Control Engineering Practice
Verified
Journal Article
Closed access
EAEleonora Maria Aiello
Eleonora Maria Aiello
MJMehrad Jaloli
Mehrad Jaloli
MCMarzia Cescon
Marzia Cescon

8 November 2023 in Control Engineering Practice
Verified
Journal Article
Closed access
MJMehrad Jaloli
Mehrad Jaloli
MCMarzia Cescon
Marzia Cescon

2 November 2021 in Cognitive Neurodynamics
Verified
Journal Article
Closed access
PDF file
FSFatemeh Salehi
Fatemeh Salehi
MJMehrad Jaloli
Mehrad Jaloli
RCRobert Coben
Robert Coben
ANAli Motie Nasrabadi
Ali Motie Nasrabadi

16 December 2022 in BioMedInformatics
Verified
Journal Article
Open access
PDF file
MJMehrad Jaloli
Mehrad Jaloli
WLWilliam Lipscomb
William Lipscomb
MCMarzia Cescon
Marzia Cescon
Behavioral factors can affect the blood glucose (BG) levels in people with type 1 diabetes (T1D), therefore, their effects need to be incorporated in blood glucose management for these individuals. Accordingly, in this work, we study the effect of two behavioral states, physical activity (PA) and stress state (SS), on BG fluctuations in individuals with T1D. We provide two methods for quantifying biomarkers related to PA and SS using raw acceleration (ACC) and electrodermal activity (EDA) data collected with a wearable device. We evaluate the impact of PA and SS on BG fluctuation by adding the derived behavior-related biomarkers in two cutting-edge deep learning-based glucose predictive models, a long short-term memory (LSTM) and a convolutional neural network (CNN)-LSTM network, for prediction horizons (PHs) of 30, 60 and 90 min. Through an ablation study, we demonstrate that incorporating the estimated behavior-related biomarkers improves the BG predictive model’s performance obtaining mean absolute error (MAE) 9.13 ± 0.95, 17.75 ± 1.93 and 31.85 ± 2.88 in [mg/dL], root mean square error (RMSE), 12.35 ± 1.06, 24.71 ± 2.31 and 41.64 ± 4.12 in [mg/dL], and coefficient of determination (R2), 95.34 ± 3.34, 78.87 ± 4.35 and 60.11 ± 4.76 in [%], for the LSTM model; and MAE 9.37 ± 0.88, 17.87 ± 1.67 and 29.47 ± 2.13 in [mg/dL], RMSE 12.51 ± 1.40, 24.37 ± 2.49 and 39.52 ± 3.89 in [mg/dL], and R2 94.65 ± 3.90, 78.37 ± 4.11 and 61.12 ± 4.30 in [%], for the CNN-LSTM model, respectively, across all PHs. Additionally, we illustrate the generalizability of the proposed models by performing both population- and patient-wise.

5 June 2023 in BioMedInformatics
Verified
Journal Article
Open access
PDF file
MJMehrad Jaloli
Mehrad Jaloli
MCMarzia Cescon
Marzia Cescon
In this study, we propose a closed-loop insulin administration framework for multiple daily injection (MDI) treatment using a reinforcement learning (RL) agent for insulin bolus therapy. The RL agent, based on the soft actor–critic (SAC) algorithm, dynamically adjusts insulin dosages based on real-time glucose readings, meal intakes, and previous actions. We evaluated the proposed strategy on ten in silico patients with type 1 diabetes undergoing MDI therapy, considering three meal scenarios. The results show that, compared to an open-loop conventional therapy, our proposed closed-loop control strategy significantly reduces glucose variability and increases the percentage of time the glucose levels remained within the target range. In particular, the weekly mean glucose level reduced from 145.34 ± 57.26 mg/dL to 115.18 ± 7.93 mg/dL, 143.62 ± 55.72 mg/dL to 115.28 ± 8.11 mg/dL, and 171.63 ± 49.30 mg/dL to 143.94 ± 23.81 mg/dL for Scenarios A, B and C, respectively. Furthermore, the percent time in range (70–180 mg/dL) significantly improved from 63.77 ± 27.90% to 91.72 ± 9.27% (p = 0.01) in Scenario A, 64.82 ± 28.06% to 92.29 ± 9.15% (p = 0.01) in Scenario B, and 58.45 ± 27.53% to 81.45 ± 26.40% (p = 0.05) in Scenario C. The model also demonstrated robustness against meal disturbances and insulin sensitivity disturbances, achieving mean glucose levels within the target range and maintaining a low risk of hypoglycemia, which were statistically significant for Scenarios B and C. The proposed model outperformed open-loop conventional therapy in all scenarios, highlighting the potential of RL-based closed-loop insulin administration models in improving diabetes management.